Adenovirus-Mediated Gene Therapy for Mucopolysaccharidosis VII: Involvement of Cross-Correction in Wide-Spread Distribution of the Gene Products and Long-Term Effects of CTLA-4Ig Coexpression
Open Access
- 31 May 2000
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 1 (5) , 406-413
- https://doi.org/10.1006/mthe.2000.0067
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Murine mucopolysaccharidosis type VII: long term therapeutic effects of enzyme replacement and enzyme replacement followed by bone marrow transplantation.Journal of Clinical Investigation, 1997
- Gaucher diseaseCurrent Opinion in Hematology, 1997
- Enzyme replacement therapy for murine mucopolysaccharidosis type VII.Journal of Clinical Investigation, 1994
- Enzyme Replacement with Recombinant β-Glucuronidase in the Newborn Mucopolysaccharidosis Type VII MousePediatric Research, 1993
- A single-base-pair deletion in the beta-glucuronidase gene accounts for the phenotype of murine mucopolysaccharidosis type VII.Proceedings of the National Academy of Sciences, 1993
- Correction of lysosomal storage in the liver and spleen of MPS VII mice by implantation of genetically modified skin fibroblastsNature Genetics, 1993
- STRUCTURE AND FUNCTION OF THE MANNOSE 6-PHOSPHATE/INSULINLIKE GROWTH FACTOR II RECEPTORSAnnual Review of Biochemistry, 1992
- Increased life span and correction of metabolic defects in murine mucopolysaccharidosis type VII after syngeneic bone marrow transplantationBlood, 1991
- Murine mucopolysaccharidosis type VII. Characterization of a mouse with beta-glucuronidase deficiency.Journal of Clinical Investigation, 1989
- Beta glucuronidase deficiency: Report of clinical, radiologic, and biochemical features of a new mucopolysaccharidosisThe Journal of Pediatrics, 1973